The Animal Imaging Core provides services for molecular imaging of rodent models of human cancer.The Core provides investigators with non-invasive, high-resolution quantitative imaging-based capabilitiesfor metabolic and genetic characterization of tumors and their microenvironment, including in vivo traffickingof tumor cells. This is accomplished by monitoring of 'directly-targeting' probes and of the expression ofsingle and multi-modality reporter genes using optical (bioluminescence and fluorescence), radionuclide(PET, SPECT, and autoradiography), MRI/MRS, CT, and US imaging. These imaging techniques are wellestablishedat MSKCC for small-animal imaging studies. They are quantitative and non-invasive and thusreadily adaptable to longitudinal studies. The Animal Imaging Core also provides investigators with accessto critical ancillary equipment and services such as a Fuji Film BAS-180011 phosphor-plate digitalautoradiography system, a digital-camera-equipped Olympus B 201 fluorescence microscope withmotorized stage, and a Microm HM500M cryostatic microtome.As part of a major expansion and modernization of MSKCC's infrastructure (Phase 1), part of the ImagingCore has recently re-located to the C4 level within the Vivarium of the new Zuckerman Research Center.This area provides enhanced biosecurity and functionality and houses our R4 and Focus 120 microPETdedicated high-resolution small-animal (rodent) PETs, new MS 200 optical imaging system, microCAT IIdedicated small-animal (rodent) CT, and X-SPECT dedicated small-animal SPECT-CT. The existing MS100 optical imaging system and recently installed Vevo 770 ultrasound system have been re-located torefurbished space on the 12th floor of the Rockefeller Research Laboratory providing improved access tothe primary users of these two systems. The Imaging Core's 4.7-T 40-cm bore and 7.0-T 31-cm BruckerNMR imaging and spectroscopy systems are currently located in the MRI Building. In Phase 2 of MSKCC'scapital expansion and modernization, all of the foregoing instrumentation of the Imaging Core will beconsolidated in spacious, state-of the-art quarters with the Center's vivarium.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA008748-43
Application #
7671810
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-07-31
Project End
2012-12-31
Budget Start
2008-07-31
Budget End
2008-12-31
Support Year
43
Fiscal Year
2008
Total Cost
$136,415
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Meyer, Jan-Philip; Tully, Kathryn M; Jackson, James et al. (2018) Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers. Bioconjug Chem 29:538-545
McFarland, Daniel C; Shaffer, Kelly; Breitbart, William et al. (2018) C-reactive protein and its association with depression in patients receiving treatment for metastatic lung cancer. Cancer :
Lacouture, Mario E; Anadkat, Milan; Jatoi, Aminah et al. (2018) Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review. Clin Colorectal Cancer 17:85-96
Blumenthal, Gideon M; Bunn Jr, Paul A; Chaft, Jamie E et al. (2018) Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer. J Thorac Oncol 13:1818-1831
Shaffer, Kelly M; Nelson, Christian J; DuHamel, Katherine N (2018) Barriers to participation in a sexual health intervention for men following treatment for rectal and anal cancer. Psychooncology 27:1082-1085
Park, Kay J; Patel, Prusha; Linkov, Irina et al. (2018) Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy. Histopathology 72:766-776
Pianko, Matthew J; Goldberg, Aaron D; Lesokhin, Alexander M (2018) Clinical Development of PD-1 Blockade in Hematologic Malignancies. Cancer J 24:31-35
Navi, Babak B; Marshall, Randolph S; Bobrow, Dylan et al. (2018) Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke: The TEACH Pilot Randomized Clinical Trial. JAMA Neurol 75:379-381
Shah, Sona; Boucai, Laura (2018) Effect of Age on Response to Therapy and Mortality in Patients With Thyroid Cancer at High Risk of Recurrence. J Clin Endocrinol Metab 103:689-697
Goldman, Debra A; Hovinga, Koos; Reiner, Anne S et al. (2018) The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis. J Neurosurg :1-9

Showing the most recent 10 out of 8799 publications